Literature DB >> 3402302

Early detection of neurological involvement in IDDM and NIDDM. Multimodal evoked potentials versus metabolic control.

G Pozzessere1, P A Rizzo, E Valle, M A Mollica, A Meccia, S Morano, U Di Mario, D Andreani, C Morocutti.   

Abstract

Clarification of the extent and mechanisms of damage to the central nervous system in diabetes is a frontier of current neurological research. Our aim was to obtain ample electrophysiological documentation of possible neurological abnormalities in both insulin-dependent (IDDM) and non-insulin-dependent (NIDDM) diabetic patients with a short duration of disease and without overt complications, taking into account metabolic control. Group 1 comprised 11 IDDM patients, and group 2 included 14 NIDDM patients treated with diet alone; the duration of disease was less than 4 yr, and no concomitant clinical complications were present. Age- and sex-matched normal subjects formed groups 3 and 4. Pattern visual evoked potentials (VEP), brain stem auditory evoked potentials (BAEP), and somatosensory evoked potentials (SEP; after the stimulation of both median and tibial nerves) were recorded in all subjects, and metabolic control was evaluated in terms of glycemia and glycosylated hemoglobin. In group 1, significant abnormalities were found in the latency values of VEP, median SEP, and tibial SEP compared with control subjects. Similar latency abnormalities were shown in group 2 for VEP, median SEP, and tibial SEP values and for wave I latency of BAEP. Glycosylated hemoglobin values were correlated with BAEP and SEP abnormalities in many patients in both groups. Furthermore, in group 2, glycemic values correlated with SEP abnormalities. We therefore conclude that neurophysiological abnormalities are present at different levels in IDDM and NIDDM patients only a few years after clinical diagnosis and before the appearance of overt complications, and these abnormalities seem to be correlated with metabolic control status.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3402302     DOI: 10.2337/diacare.11.6.473

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  15 in total

1.  Central motor conduction after magnetic stimulation in diabetes.

Authors:  A Moglia; A Arrigo; M Maurelli; E Alfonsi; A Bodini; A Lozza; M T Tenconi; S B Solerte; E Ferrari
Journal:  Ital J Neurol Sci       Date:  1998-02

2.  Changes in central and peripheral nervous system function during hypoglycemia in man: an electro-physiological quantification.

Authors:  G Tamburrano; N Locuratolo; G Pozzessere; O Lostia; S Caiola; E Valle; F Bianco; A Giaccari; P A Rizzo
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

3.  Spatial frequency-selective losses with pattern electroretinogram in type 1 (insulin-dependent) diabetic patients without retinopathy.

Authors:  M A Di Leo; B Falsini; S Caputo; G Ghirlanda; V Porciatti; A V Greco
Journal:  Diabetologia       Date:  1990-12       Impact factor: 10.122

4.  To Study Brain Stem Auditory Evoked Potential in Patients with Type 2 Diabetes Mellitus- A Cross- Sectional Comparative Study.

Authors:  Mishra Indira Sushil; J N Muneshwar; Sayeeda Afroz
Journal:  J Clin Diagn Res       Date:  2016-11-01

5.  Insulin and IGF-I prevent brain atrophy and DNA loss in diabetes.

Authors:  Predrag Serbedzija; James E Madl; Douglas N Ishii
Journal:  Brain Res       Date:  2009-09-23       Impact factor: 3.252

6.  Effects of hyperglycaemia on visual evoked potentials in insulin-dependent diabetic patients.

Authors:  V Martinelli; P M Piatti; M Filippi; M Pacchioni; M R Pastore; N Canal; G Comi
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

7.  Tibial nerve somatosensory evoked potentials at various stages of peripheral neuropathy in insulin dependent diabetic patients.

Authors:  D Ziegler; H Mühlen; K Dannehl; F A Gries
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-01       Impact factor: 10.154

Review 8.  Cognitive dysfunction and diabetes mellitus.

Authors:  Christopher T Kodl; Elizabeth R Seaquist
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

9.  Reduced insulin-like growth factor-I mRNA content in liver, adrenal glands and spinal cord of diabetic rats.

Authors:  D N Ishii; D M Guertin; L R Whalen
Journal:  Diabetologia       Date:  1994-11       Impact factor: 10.122

Review 10.  Cerebral function in diabetes mellitus.

Authors:  G J Biessels; A C Kappelle; B Bravenboer; D W Erkelens; W H Gispen
Journal:  Diabetologia       Date:  1994-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.